Back
Summit Therapeutics, Inc. Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
46
SMMT
Summit Therapeutics, Inc.
Last Price:
$18.31
Seasonality Move:
26.83%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is relatively stagnant and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
Summit Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.92 | Buy |
| 20-day SMA: | 17.75 | Buy |
| 50-day SMA: | 19.31 | Sell |
| 200-day SMA: | 21.98 | Sell |
| 8-day EMA: | 17.99 | Buy |
| 20-day EMA: | 17.99 | Buy |
| 50-day EMA: | 19.08 | Sell |
| 200-day EMA: | 20.58 | Sell |
Summit Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 50.81 | Buy |
| Chaikin Money Flow: | -1337288 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.05 - 18.63) | Buy |
| Bollinger Bands (100): | (18 - 25.74) | Sell |
Summit Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics, Inc. Stock
Is Summit Therapeutics, Inc. Stock a Buy?
-
Summit Therapeutics, Inc. share price is 18.31 while SMMT 8-day simple moving average is 17.92, which is a Buy signal.
-
The stock price of SMMT is 18.31 while Summit Therapeutics, Inc. 20-day SMA is 17.75, which makes it a Buy.
-
Summit Therapeutics, Inc. 50-day simple moving average is 19.31 while SMMT share price is 18.31, making it a Sell technically.
-
SMMT stock price is 18.31 and Summit Therapeutics, Inc. 200-day simple moving average is 21.98, creating a Sell signal.
SMMT Technical Analysis vs Fundamental Analysis
Sell
46
Summit Therapeutics, Inc. (SMMT)
is a Sell
Is Summit Therapeutics, Inc. a Buy or a Sell?
-
Summit Therapeutics, Inc. stock is rated a SellThe current Summit Therapeutics, Inc. [SMMT] share price is $18.31. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Summit Therapeutics, Inc. Stock Info
Market Cap:
13.6B
Price in USD:
18.31
Share Volume:
2.4M
Summit Therapeutics, Inc. 52-Week Range
52-Week High:
36.91
52-Week Low:
15.55
Sell
46
Summit Therapeutics, Inc. (SMMT)
is a Sell
Summit Therapeutics, Inc. Share Price Forecast
-
What is the Summit Therapeutics, Inc. stock price today?The Summit Therapeutics, Inc. stock price is 18.31 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics, Inc. is overvalued.
Is Summit Therapeutics, Inc. Stock a Buy?
-
Summit Therapeutics, Inc. share price is 18.31 while SMMT 8-day exponential moving average is 17.99, which is a Buy signal.
-
The stock price of SMMT is 18.31 while Summit Therapeutics, Inc. 20-day EMA is 17.99, which makes it a Buy.
-
Summit Therapeutics, Inc. 50-day exponential moving average is 19.08 while SMMT share price is 18.31, making it a Sell technically.
-
SMMT stock price is 18.31 and Summit Therapeutics, Inc. 200-day simple moving average is 20.58, creating a Sell signal.
Fundamental Analysis of Summit Therapeutics, Inc.
Is Summit Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and an increase next year of $0.03 per share.
Technical Analysis of Summit Therapeutics, Inc.
Should I short Summit Therapeutics, Inc. stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is -0.28, suggesting Summit Therapeutics, Inc. is a Sell
-
Summit Therapeutics, Inc. Relative Strength Index (RSI) is 50.81, which suggest Summit Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Summit Therapeutics, Inc. is (17.05 - 18.63), which suggest Summit Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Summit Therapeutics, Inc. is (18 - 25.74), which suggest Summit Therapeutics, Inc. is a Sell
* Summit Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.